TW200637817A - 5-aminoindole derivatives - Google Patents

5-aminoindole derivatives

Info

Publication number
TW200637817A
TW200637817A TW095101738A TW95101738A TW200637817A TW 200637817 A TW200637817 A TW 200637817A TW 095101738 A TW095101738 A TW 095101738A TW 95101738 A TW95101738 A TW 95101738A TW 200637817 A TW200637817 A TW 200637817A
Authority
TW
Taiwan
Prior art keywords
compounds
aminoindole derivatives
aminoindole
derivatives
receptors
Prior art date
Application number
TW095101738A
Other languages
English (en)
Inventor
Matthias Heinrich Nettekoven
Jean-Marc Plancher
Olivier Roche
Rosa Maria Rodriguez-Sarmiento
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TW200637817A publication Critical patent/TW200637817A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095101738A 2005-01-19 2006-01-17 5-aminoindole derivatives TW200637817A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05100312 2005-01-19

Publications (1)

Publication Number Publication Date
TW200637817A true TW200637817A (en) 2006-11-01

Family

ID=36540146

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095101738A TW200637817A (en) 2005-01-19 2006-01-17 5-aminoindole derivatives

Country Status (16)

Country Link
US (2) US7456174B2 (zh)
EP (1) EP1841734B1 (zh)
JP (1) JP2008527014A (zh)
KR (1) KR100902707B1 (zh)
CN (1) CN101107227B (zh)
AR (1) AR053435A1 (zh)
AT (1) ATE437856T1 (zh)
AU (1) AU2006207712A1 (zh)
BR (1) BRPI0606502A2 (zh)
CA (1) CA2594487A1 (zh)
DE (1) DE602006008104D1 (zh)
ES (1) ES2327776T3 (zh)
IL (1) IL184433A0 (zh)
MX (1) MX2007008676A (zh)
TW (1) TW200637817A (zh)
WO (1) WO2006077024A2 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040096216A (ko) 2003-05-07 2004-11-16 삼성전자주식회사 제빵기
AR048134A1 (es) * 2003-12-15 2006-04-05 Lundbeck & Co As H La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial
AU2006326135A1 (en) * 2005-12-15 2007-06-21 F. Hoffmann-La Roche Ag Pyrrolo[2,3-c]pyridine derivatives
US7834050B2 (en) * 2006-03-29 2010-11-16 Duke University Small molecule insulin mimetics absent quinones
CA2647440A1 (en) * 2006-04-12 2007-10-18 Matthias Nettekoven 5-amido-2-carboxamide indoles
US7432255B2 (en) * 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
US7514433B2 (en) * 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
TW200823204A (en) * 2006-10-17 2008-06-01 Arena Pharm Inc Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
US7648979B2 (en) * 2007-02-07 2010-01-19 Hoffmann-La Roche Inc. 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives
WO2008109333A1 (en) * 2007-03-01 2008-09-12 Janssen Pharmaceutica N.V. Indole and benzothiophene compounds as modulators of the histamine h3 receptor
KR20100027231A (ko) 2007-07-25 2010-03-10 에프. 호프만-라 로슈 아게 벤조퓨란- 및 벤조[ｂ]티오펜-2-카복실산 아마이드 유도체 및 이의 히스타민 3 수용체 조절제로서의 용도
CN106905286B (zh) * 2015-12-23 2020-07-24 江苏恩华药业股份有限公司 一种黄酮类化合物衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705095B1 (fr) * 1993-05-12 1995-06-23 Adir Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5756507A (en) * 1995-12-14 1998-05-26 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
BR9814018A (pt) * 1997-11-11 2000-09-26 Pfizer Prod Inc Derivados de tienopirimidina e tienopiridina úteis como agentes anticâncer
EP1268421B1 (en) * 2000-03-31 2009-05-06 Ortho-McNeil Pharmaceutical, Inc. Phenyl-substituted indoles as histamine h3-receptor antagonists
ES2213693T3 (es) * 2000-03-31 2004-09-01 Ortho-Mcneil Pharmaceutical, Inc. Derivados de indolizina fenil-sustituidos y su uso como ligandos del receptor h3 de la histamina.
CN1293072C (zh) * 2001-04-20 2007-01-03 惠氏公司 作为5－羟色胺－6配体的杂环基氧基－、－硫代－和－氨基吲哚衍生物
DK1539742T3 (da) * 2002-06-24 2006-12-27 Schering Corp Indolderivater, der er nyttige som histamin H3-antagonister
MXPA06014810A (es) * 2004-06-21 2007-02-12 Hoffmann La Roche Derivados de indol como antagonistas receptores de histamina.

Also Published As

Publication number Publication date
DE602006008104D1 (de) 2009-09-10
CA2594487A1 (en) 2006-07-27
AR053435A1 (es) 2007-05-09
US20090069311A1 (en) 2009-03-12
US20060160855A1 (en) 2006-07-20
US7456174B2 (en) 2008-11-25
IL184433A0 (en) 2007-10-31
EP1841734B1 (en) 2009-07-29
ATE437856T1 (de) 2009-08-15
KR100902707B1 (ko) 2009-06-15
CN101107227A (zh) 2008-01-16
EP1841734A2 (en) 2007-10-10
AU2006207712A1 (en) 2006-07-27
KR20070098922A (ko) 2007-10-05
JP2008527014A (ja) 2008-07-24
MX2007008676A (es) 2007-07-25
WO2006077024A2 (en) 2006-07-27
WO2006077024A3 (en) 2006-09-08
BRPI0606502A2 (pt) 2009-06-30
CN101107227B (zh) 2010-09-22
US7754736B2 (en) 2010-07-13
ES2327776T3 (es) 2009-11-03

Similar Documents

Publication Publication Date Title
TW200612936A (en) Indole derivatives
TW200637817A (en) 5-aminoindole derivatives
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
ATE517882T1 (de) Chinolinderivate
TW200626158A (en) Naphthaline derivatives
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
WO2007062999A3 (en) 1,5-substituted indol-2-yl amide derivatives
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
TW200716547A (en) Piperidin-4-yl-amide derivatives
NO20082096L (no) Azaindol-2-karboksamidderivativer
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
MX2009012518A (es) Derivados de piperidina 4,4-disubstituidos.
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
TW200800993A (en) Organic compounds
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
DE602008002598D1 (en) Cyclohexylderivate